The NeurologyLive® Insomnia Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with the disorder of sleepiness.
March 11th 2024
A meta-analysis on studies assessing FDA-approved dual orexin receptor antagonists for insomnia treatment highlighted a greater risk of adverse events, particularly for narcolepsy-like symptoms.
Impact of Technology, Screen Time on Sleep in Children, Adolescents: Jodi A. Mindell, PhD
September 7th 2022The associate director of the Sleep Center at Children’s Hospital of Philadelphia provided context on the ever-expanding world of technology and the harmful effects it can have on children’s sleep. [WATCH TIME: 3 minutes]
Impaired Sleep, Subclinical Insomnia More Common During COVID-19 Pandemic
September 6th 2022Stringent governmental measures predicted lower global scores on Pittsburgh Sleep Quality Index, while, albeit to a small extent, less restrictive measures were related to worse subjective sleep quality.
The Need for More Sleep Education in Medicine: Yuri Maricich, MD, MBA
September 4th 2022The internal medicine physician and chief medical officer and head of development at Pear Therapeutics offered his perspective on the current focus that is given to sleep in clinical care and the lack of education on interventions. [WATCH TIME: 2 minutes]
The Cumulative Effect of Chronic Insomnia: Yuri Maricich, MD, MBA
September 1st 2022The internal medicine physician and chief medical officer and head of development at Pear Therapeutics spoke about the long-term impacts that uncontrolled insomnia can have on patients with chronic disease. [WATCH TIME: 3 minutes]
Combination of PTSD and Insomnia Elevates Risk for Major Cardiovascular Events
August 31st 2022Even after adjusting for multiple confounding variables including recognized factors associated with cardiovascular diseases, PTSD plus insomnia remained an independent factor of major adverse cardiovascular events.
Overview of the Prevalence and Variety of Pediatric Sleep Disorders: Carol Rosen, MD
August 31st 2022The professor of pediatrics at Case Western University provided insight on the typical sleep issues seen in children and adolescents, and how they impact overall quality of life. [WATCH TIME: 5 minutes]
Prescribed Hypnotic Medications, Not Insomnia Diagnosis, Cause Increased Risk for Serious Falls
July 28th 2022Findings showed that, although risk for serious fall injury was not mitigated by insomnia diagnosis, individuals with active insomnia taking prescribed hypnotic medication may be a particularly high-risk subgroup.
Understanding Individual Risks, Improving Trial Designs for Sleep Disorders in Alzheimer Disease
July 7th 2022Ruth Benca, MD, PhD, a professor and the chair of Psychiatry & Human Behavior at Wake Forest School of Medicine, provided insight on the age- and sex-related differences in sleep disorders, and the needed research on the effects of therapeutics in older populations.